Refine
Document Type
- Article (3)
- Part of a Book (1)
Has Fulltext
- yes (4)
Is part of the Bibliography
- no (4)
Keywords
- Anaheim, Calif. / Disneyland (1)
- Aspergillus nidulans (1)
- Freizeitpark (1)
- Fungal genetics (1)
- Fungal spores (1)
- Gene expression (1)
- Gene regulation (1)
- Geschichtsdarstellung (1)
- Oxidative stress (1)
- Secondary metabolism (1)
Institute
- Biowissenschaften (2)
- Medizin (1)
Ausgehend von einer Definition von Themenparks als Heterotopien entwickelt der Beitrag ein vierstufiges Modell geschichtstransformatorischer Strategien, die in Themenparks einen affektiven Zugang zu einer ideologisierten, kommodifizierten und präsentifizierten Vergangenheit ermöglichen. Diese grundlegende Neukonzeption von Vergangenheit, die sich allenfalls punktuell an Maßstäben von Authentizität orientiert, gleichwohl jedoch als ungemein wirkmächtig erachtet werden muss, verortet der Beitrag in einer breiteren ästhetischen und kulturellen Entwicklung der Postmoderne, die als 'affective turn' bezeichnet worden ist. Das Modell der geschichtstransformatorischen Strategien wird in der Folge anhand von zwei Fallbeispielen - Main Street, U.S.A. in Disneyland und Grecia in Terra Mítica - illustriert, wobei besonders auf den historischen und kulturellen Kontext der Parks eingegangen wird, der bei Geschichtstransformationen in Themenparks eine kaum zu überschätzende Rolle spielt.
The NF-κB-like velvet domain protein VosA (viability of spores) binds to more than 1,500 promoter sequences in the filamentous fungus Aspergillus nidulans. VosA inhibits premature induction of the developmental activator gene brlA, which promotes asexual spore formation in response to environmental cues as light. VosA represses a novel genetic network controlled by the sclB gene. Bfunction is antagonistic to VosA, because it induces the expression of early activator genes of asexual differentiation as flbC and flbD as well as brlA. The SclB controlled network promotes asexual development and spore viability, but is independent of the fungal light control. SclB interactions with the RcoA transcriptional repressor subunit suggest additional inhibitory functions on transcription. SclB links asexual spore formation to the synthesis of secondary metabolites including emericellamides, austinol as well as dehydroaustinol and activates the oxidative stress response of the fungus. The fungal VosA-SclB regulatory system of transcription includes a VosA control of the sclB promoter, common and opposite VosA and SclB control functions of fungal development and several additional regulatory genes. The relationship between VosA and SclB illustrates the presence of a convoluted surveillance apparatus of transcriptional control, which is required for accurate fungal development and the linkage to the appropriate secondary metabolism.
Gliflozins are inhibitors of the renal proximal tubular sodium-glucose co-transporter-2 (SGLT-2), that inhibit reabsorption of urinary glucose and they are able to reduce hyperglycemia in patients with type 2 diabetes. A renoprotective function of gliflozins has been proven in diabetic nephropathy, but harmful side effects on the kidney have also been described. In the current project, primary highly purified human renal proximal tubular epithelial cells (PTCs) have been shown to express functional SGLT-2, and were used as an in vitro model to study possible cellular damage induced by two therapeutically used gliflozins: empagliflozin and dapagliflozin. Cell viability, proliferation, and cytotoxicity assays revealed that neither empagliflozin nor dapagliflozin induce effects in PTCs cultured in a hyperglycemic environment, or in co-medication with ramipril or hydro-chloro-thiazide. Oxidative stress was significantly lowered by dapagliflozin but not by empagliflozin. No effect of either inhibitor could be detected on mRNA and protein expression of the pro-inflammatory cytokine interleukin-6 and the renal injury markers KIM-1 and NGAL. In conclusion, empa- and dapagliflozin in therapeutic concentrations were shown to induce no direct cell injury in cultured primary renal PTCs in hyperglycemic conditions.